Dzugkoev S.G., Garmash O.Yu., Dzugkoeva F.S. Pathogenetic rationale for using an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and an antioxidant coenzyme Q10 in the treatment and prevention of cardiovascular disease. Cardiovascular Therapy and Prevention. 2021;20(6):2793. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2793
Editor-in-Chief
Drapkina O. M.
Email this article (Login required)
Email the author (Login required) 101000, Moscow, Petroverigsky per., 10, str. 3
National medical research center for therapy and preventive medicine
Тел: +7 (499) 553 67 78
Editorial office Cardiovascular Therapy and Prevention
Processing of personal data
